Normal and neoplastic stem cells
26 Apr 2016
Normal and neoplastic stem cells
WIN 2016: Preview of themes
WIN 2016: Preview of Speakers
Management of CLL patients in the front-line setting: live broadcast
Update on new agents in multiple myeloma – focus on monoclonal antibodies: an expert roundtable discussion
Novel agents before and after stem cell transplantation for myeloma
Immunology highlights from the ITOC-3 conference
EBMT 2016 Highlights: Expert discussion
Novel technologies for understanding the repertoire of tumour infiltrating T cells in cancer
Targeting AFP in hepatocellular cancer
Combination of viroimmunotherapy with checkpoint inhibitors
Is PD-L1 really a predictive biomarker?